0.40% -0.06

Acadia Pharmaceuticals Inc (ACAD)

Acadia Pharmaceuticals Inc (ACAD) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	9.14% 231.04	211.70	165.24	118.46	136.49
Cost Of Revenue	22.35% 17.89	14.62	7.459	1.667	2.414
Gross Profit	8.16% 213.15	197.08	157.78	116.80	134.08
Operating Expenses	30.07% 178.21	254.85	154.74	170.38	180.14
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	100.00% -	269.48	162.20	172.05	-
Operating Income/Loss	160.48% 34.94	-57.78	3.037	-53.58	-46.06
Income/Loss From Continuing Operations Before Tax	543.09% 231.04	-52.14	6.343	-44.94	136.49
Income Tax Expense/Benefit	146.76% -6.094	13.03	5.229	-1.918	0.835
Income/Loss From Continuing Operations After Tax	170.27% 45.80	-65.18	1.114	-43.02	-41.73
Net Income/Loss	170.27% 45.80	-65.18	1.114	-43.02	-41.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.80% 0.000331	0.1642	0.1635	162.26	0.000103
Diluted Average Shares	99.80% 0.000331	0.1642	0.165	162.26	0.000103
Basic Earnings Per Share	170.00% 0.28	-0.40	0.01	-0.27	-0.26
Diluted Earnings Per Share	170.00% 0.28	-0.40	0.01	-0.27	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-